Investing
Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results
Antilles Gold Limited (“Antilles Gold” or the “Company”) (ASX Code: AAU, OTCQB: ANTMF) advises that an announcement lodged with ASX...
Read more
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research...
Read more
Hertz Energy Inc. Announces Resignation Of Director
(TheNewswire) Vancouver, British Columbia The Newswire October 11, 2024 Hertz Energy Inc. (CSE: HZ; OTCQB: HZLIF; FSE: QE2) (the ‘...
Read more
West High YieldResources Ltd. Announces Extension of Current Private Placement
West High Yield (W.H.Y.) Resources Ltd. (TSXV: WHY) (‘West High Yield’ or the ‘Company’) announces that, further to its news...
Read more
Tech 5: AI Advances Win Nobel Prizes, Autonomous Tesla Falls Flat
The Royal Swedish Academy of Sciences recognized advancements in artificial intelligence (AI) this week, handing out two prizes to researchers...
Read more
Top 5 Canadian Mining Stocks This Week: American Lithium Charges Up 78 Percent
The S&P/TSX Venture Composite Index (INDEXTSI:JX) was up 0.96 percent on the week to 595.59 by 12:00 p.m. EDT on...
Read more
NextSource Materials Closes Private Placement for Gross Proceeds of CAD$14.7 Million
Not for distribution to U.S. news wire services or for dissemination in the United States or to a U.S. Person....
Read more
Suki Secures US$70M to Drive AI-Assisted Healthcare Solutions
Suki AI, a healthcare-focused startup, has secured US$70 million in a Series D funding round aimed at further developing its...
Read more
Skyharbour’s Partner North Shore Continues Drill Target Generation at Falcon Uranium Project
Skyharbour Resources Ltd. (TSX-V: SYH ) (OTCQX: SYHBF ) (Frankfurt: SC1P ) (‘Skyharbour’ or the ‘Company’), is pleased to announce...
Read more
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company focused on the research...
Read more
